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The opportunity to read, download, and cite the Journal's archival material back to and including the original issue in January of 1944 became a reality in 2008 when the Executive Committee and Board of Directors of the American Association of Neurological Surgeons (AANS) voted in favor of digitizing the Journal's back issues online. The decision to host this legacy material on the Journal of Neurosurgery Publishing Group (JNSPG) website must be construed as one of the most tangible benefits offered to AANS members, and the articles are available to other clinicians and investigators through institutional subscriptions. Issues of journal articles are now fully searchable back to 1944 and are linked to PubMed articles back to 1957.
Just as we celebrate those articles in the inaugural issue of the Journal, so it is worth a moment to reflect on the future impact of articles being published now, 70 years later, in this, the final issue of the 2014 volume. Kodama et al. from Frankfurt am Main, Germany, describe their experience with somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) in a series of 210 patients with infratentorial lesions. 5 These techniques in neuromonitoring were not available in 1944 when posterior fossa surgery was still considered somewhat of an unchartered territory. Now, 70 years later, SEPs and MEPs have become commonplace neuromonitoring strategies throughout the world and have arguably led to better outcomes in patients. It is quite possible they will become a "standard of care" in the future for the resection of deep, central supratentorial brain tumors, large cerebral arteriovenous malformations, and intramedullary spinal cord tumors.
In a laboratory investigation that heralds the application of a "personalized medicine" approach to human brain tumors, Agnihotri and colleagues from Toronto, Canada, use gene-expression profiling to identify molecular signaling networks that have the potential to be targeted therapeutically in vestibular schwannoma.
1 Interestingly, the authors demonstrated that germline-associated and sporadic schwannomas are molecularly indistinct and that the phosphoinositide 3-kinase-AKT-mammalian target of rapamycin (PI3K/AKT/mTOR) signaling networks are activated in these tumors. The latter discovery opens the possibility that vestibular schwannomas may be "druggable" tumors with dual PI3K and mTOR inhibitors, much the same as subependymal giant cell astrocytomas (SEGAs) in tuberous sclerosis have been shown to be responsive to the mTOR inhibitor, rapamycin.
2 Harvey Cushing, who, throughout his career, considered vestibular schwannomas to be formidable tumors, would have been pleased to know that there may ultimately be a drug to treat these lesions.
As a final example, Gómez et al. from Madrid, Spain, have described a new prognostic score for predicting early mortality in severe head injury cases. 3 They have validated and shown that the combination of the Glasgow Coma Scale (GCS) as described by Teasdale and Jennett, 10 CT Editorial scanning results, and secondary injury data allowed for an improved prediction of early mortality in patients with traumatic brain injury (TBI). While the GCS has been the most reliable TBI scale used over the past 40 years, it is possible that refinements in its predictive power, as underscored by Gómez, may be extremely important in clinical trials design and in helping to shape health care policy decisions. These 3 studies, among several others in this final issue of 2014, illustrate the proclivity of the Journal to publish high-impact research papers from centers around the world. With an impact factor of 3.227 in 2013, the highest among all specialty journals in neurosurgery, it may not be surprising that our global partners have selected the Journal of Neurosurgery in which to publish their best works.
This past year, I was delighted to lead a strategic planning process for 2015-2017 for the JNSPG. There are 5 main pillars of our plan: 1) Global position, outreach, and influence; 2) Innovations in presentation formats; 3) Collaborations and synergies with associative partners; 4) Enhancement of the efficiencies of the editorial office; and 5) Development of a sustainable business plan. As part of the new strategic plan, we worked progressively toward a redesign of the cover and internal format of all JNSPG journals. When compared to previous iterations of the Journal of Neurosurgery's cover (Fig. 1) , the redesign, which is set to launch in January 2015, will demonstrate our strong desire to maintain an authoritative cover, and to continue to lead in content, readability, accessibility, and linkages to state-of-the-art formats for editorials, video sequences, and podcasts, among many other refinements. For the journal redesign, I should like to thank the editorial staff in Charlottesville for their unwavering engagement throughout the entire process. For those interested, our new strategic plan-"Tradition-Transition-Transformation"-can be found for review at http:// thejns.org/page/about.
I would also like to welcome Dr. Douglas Kondziolka as the new Associate Editor of the Journal and at the same moment thank Dr. Ed Oldfield for his incredible contributions over many years in this capacity. Finally, I would be remiss in not recognizing the extraordinary continued commitment of Dr. John A. Jane Sr., Editor Emeritus, in all aspects of the JNSPG's welfare. While not divulged here, I encourage all of you to examine carefully next month's issue of the Journal to see the progressive changes that I have alluded to. You will see that we are still the "white journal" but for a new era in neurosurgical publishing.
